Telotristat etiprate

BNF:
Not listed
Status:
Red
Decision Date:
December 2017
 

Comments

RED: treatment of carcinoid syndrome diarrhoea in combination with somatostatin analogue therapy.

to be used in line NHSE commissioning intentions.

search again